ArticlebioRxiv : the preprint server for biology2025
"Frustratingly easy" domain adaptation for cross-species transcription factor binding prediction.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Motivation: Understanding how DNA sequence encodes gene regulation remains a central challenge in genomics. While deep learning models can predict regulatory activity from sequence with high accuracy, their generalizability across species-and thus their ability to capture fundamental biological principles-remains limited. Cross-species prediction provides a powerful test of model robustness and offers a window into conserved regulatory logic, but effectively bridging species-specific genomic differences remains a major barrier. Results: We present MORALE, a novel and scalable domain adaptation framework that significantly advances cross-species prediction of transcription factor (TF) binding. By aligning statistical moments of sequence embeddings across species, MORALE enables deep learning models to learn species-invariant regulatory features without requiring adversarial training or complex architectures. Applied to multi-species TF ChIP-seq datasets, MORALE achieves state-of-the-art performance-outperforming both baseline and adversarial approaches across all TFs-while preserving model interpretability and recovering canonical motifs with greater precision. In the five-species transfer setting, MORALE not only improves human prediction accuracy beyond human-only training but also reveals regulatory features conserved across mammals. These results highlight the potential of simple yet powerful domain adaptation techniques to drive generalization and discovery in regulatory genomics. Crucially, MORALE is architecture-agnostic and can be seamlessly integrated into any embedding-based sequence model. Availability: Code is available at https://github.com/loudrxiv/frustrating.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.